Experimental phage therapy targets stubborn lung infection in single patient
Disease control
ENROLLING_BY_INVITATION
This study tests a special virus called a bacteriophage, combined with standard antibiotics, to treat a serious lung infection caused by Mycobacterium abscessus. Only one patient will take part, receiving a personalized phage therapy designed to attack the bacteria. The goal is t…
Phase: PHASE1 • Sponsor: Vancouver Coastal Health • Aim: Disease control
Last updated May 18, 2026 12:01 UTC